Skip to content

Clinical trials

Phase 2 Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: United States Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20014
20024
200312
20049
20055
20066
20073
20088
20098
20104
20119
20126
20137
20144
20157
20166
20176
20182
20197
20203
20213
20225
20235
20243
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Terminated25
Recruiting18
Withdrawn8
Unknown status6
Active, not recruiting4
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
US Department of Veterans Affairs13
Johns Hopkins University9
National Institute of Neurological Disorders and Stroke (NINDS)9
Duke University5
VA Office of Research and Development4
Allergan3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Northwell Health3
University of California, Irvine3
University of California, Los Angeles3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke160
Ischemic Stroke35
Paresis10
Aphasia7
Ischemia7
Thrombosis7
Atrial Fibrillation6
Hemiplegia5
Muscle Spasticity5
Deglutition Disorders4

Trials

Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.